- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06141486
Effekt- og sikkerhetsstudie av Frexalimab (SAR441344) hos voksne med ikke-tilbakefallende sekundær progressiv multippel sklerose (FREVIVA)
En randomisert, dobbeltblind fase 3-studie som sammenligner effektivitet og sikkerhet av Frexalimab (SAR441344) med placebo hos voksne deltakere med ikke-relapsende sekundær progressiv multippel sklerose
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months double-blind administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with nrSPMS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include:
- This event-driven study will end when the target number of 6-month cCDP events is achieved, and the study is expected to last 43 months from randomization of the first participant to the common study end.
- The number of scheduled visits will be up to 25 (including 3 follow-up visits) with a visit frequency of every month for the first 6 months and then every 3 months.
- If the prespecified number of events for 6-month cCDP is not reached by V21/W180, scheduled visits will continue every 3 months.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
-
Buenos Aires, Argentina, 1425
- Investigational Site Number : 0320001
-
Buenos Aires, Argentina, 1012
- Investigational Site Number : 0320002
-
Buenos Aires, Argentina, 1055
- Investigational Site Number : 0321010
-
Buenos Aires, Argentina, 1060
- Investigational Site Number : 0320007
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320003
-
-
-
-
New South Wales
-
Saint Leonards, New South Wales, Australia, 2065
- Investigational Site Number : 0360005
-
-
Queensland
-
Woolloongabba, Queensland, Australia, 4102
- Investigational Site Number : 0360001
-
-
Victoria
-
Melbourne, Victoria, Australia, 3084
- Investigational Site Number : 0360002
-
-
-
-
-
Bruges, Belgia, 8000
- Investigational Site Number : 0560001
-
Brussels, Belgia, 1200
- Investigational Site Number : 0560008
-
Ghent, Belgia, 9000
- Investigational Site Number : 0560006
-
Kortrijk, Belgia, 8500
- Investigational Site Number : 0560007
-
Melsbroek, Belgia, 1820
- Investigational Site Number : 0560003
-
Overpelt, Belgia, 3900
- Investigational Site Number : 0560005
-
-
-
-
-
São Paulo, Brasil, 01228-000
- CPHosp Medicina, Ensino e Pesquisa (CPQuali)- Site Number : 0760002
-
São Paulo, Brasil, 04038-002
- PSEG Centro de Pesquisa Clínica- Site Number : 0760021
-
São Paulo, Brasil, 04515-000
- Jordy Sinapse- Site Number : 0760004
-
São Paulo, Brasil, 05651-901
- Hospital Israelita Albert Einstein- Site Number : 0760026
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brasil, 29055-450
- Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760029
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, Brasil, 41820-020
- Centro de Pesquisas da Clínica IBIS- Site Number : 0760030
-
-
Federal District
-
Brasília, Federal District, Brasil, 70200-730
- L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003
-
-
Goiás
-
Goiânia, Goiás, Brasil, 74605-020
- Universidade Federal de Goias- Site Number : 0760024
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasil, 30150-320
- Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site Number : 0760025
-
-
Paraná
-
Curitiba, Paraná, Brasil, 81210-310
- Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760001
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasil, 90035-902
- Hospital Moinhos de Vento- Site Number : 0760005
-
Porto Alegre, Rio Grande do Sul, Brasil, 90110-000
- IMV Pesquisa Neurológica- Site Number : 0760031
-
Porto Alegre, Rio Grande do Sul, Brasil, 90480-020
- Instituto Ceos- Site Number : 0760028
-
-
Santa Catarina
-
Joinville, Santa Catarina, Brasil, 89202-165
- Clínica Neurológica- Site Number : 0760007
-
-
São Paulo
-
Santo André, São Paulo, Brasil, 09040-010
- Prognosis Centro de Pesquisa- Site Number : 0760032
-
-
-
-
-
Blagoevgrad, Bulgaria, 2700
- Investigational Site Number : 1000009
-
Panagyurishte, Bulgaria, 4500
- Investigational Site Number : 1000008
-
Pazardzhik, Bulgaria, 4400
- Investigational Site Number : 1000007
-
Pleven, Bulgaria, 5800
- Investigational Site Number : 1000010
-
Pleven, Bulgaria, 5800
- Investigational Site Number : 1000002
-
Sofia, Bulgaria, 1431
- Investigational Site Number : 1000001
-
Sofia, Bulgaria, 1407
- Investigational Site Number : 1000004
-
Sofia, Bulgaria, 1606
- Investigational Site Number : 1000006
-
Sofia, Bulgaria, 1680
- Investigational Site Number : 1000005
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Investigational Site Number : 1240011
-
-
British Columbia
-
Burnaby, British Columbia, Canada, V5G 2X6
- Investigational Site Number : 1240005
-
Vancouver, British Columbia, Canada, V6T 2B5
- Investigational Site Number : 1240010
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 2Z3
- Investigational Site Number : 1240018
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- Investigational Site Number : 1240014
-
Ottawa, Ontario, Canada, K1H 8L6
- Investigational Site Number : 1240002
-
Toronto, Ontario, Canada, M4N 3M5
- Investigational Site Number : 1240015
-
Toronto, Ontario, Canada, M5B 1W8
- Investigational Site Number : 1240012
-
-
Quebec
-
Gatineau, Quebec, Canada, J8Y 1W2
- Investigational Site Number : 1240001
-
Lévis, Quebec, Canada, G6W 0M5
- Investigational Site Number : 1240008
-
Montreal, Quebec, Canada, H2X 3E4
- Investigational Site Number : 1240009
-
Québec, Quebec, Canada, G1J 1Z4
- Investigational Site Number : 1240003
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Investigational Site Number : 1240006
-
-
-
-
Reg Metropolitana de Santiago
-
Santiago, Reg Metropolitana de Santiago, Chile, 8380456
- Investigational Site Number : 1520001
-
Santiago, Reg Metropolitana de Santiago, Chile, 8320325
- Investigational Site Number : 1520002
-
-
-
-
Alabama
-
Homewood, Alabama, Forente stater, 35209
- Alabama Neurology Associates- Site Number : 8400115
-
-
Arizona
-
Scottsdale, Arizona, Forente stater, 85253
- Perseverance Research Center- Site Number : 8400138
-
Scottsdale, Arizona, Forente stater, 85258
- Imaging Endpoints- Site Number : 8400050
-
-
California
-
Berkeley, California, Forente stater, 94705
- Sutter East Bay Medical Foundation - Berkeley- Site Number : 8400134
-
Irvine, California, Forente stater, 92697
- University of California Irvine - School of Medicine- Site Number : 8400143
-
La Jolla, California, Forente stater, 92037
- University of California San Diego - La Jolla- Site Number : 8400095
-
Los Angeles, California, Forente stater, 90027
- Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400184
-
Newport Beach, California, Forente stater, 92663
- Hoag Memorial Hospital Presbyterian- Site Number : 8400031
-
Palo Alto, California, Forente stater, 94304
- Stanford Neuroscience Health Center- Site Number : 8400120
-
West Hollywood, California, Forente stater, 90048
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80045
- University of Colorado - Anschutz Medical Campus- Site Number : 8400001
-
Fort Collins, Colorado, Forente stater, 80528
- Advanced Neurology of Colorado- Site Number : 8400148
-
-
Connecticut
-
New Haven, Connecticut, Forente stater, 06510
- Yale University School of Medicine- Site Number : 8400081
-
Norwich, Connecticut, Forente stater, 06360
- Hartford Healthcare Medical Group- Site Number : 8400069
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20007
- MedStar Georgetown University Hospital- Site Number : 8400044
-
-
Florida
-
Altamonte Springs, Florida, Forente stater, 32714
- Neurology of Central Florida- Site Number : 8400147
-
Clearwater, Florida, Forente stater, 33761
- MS & Neuromuscular Center of Excellence- Site Number : 8400015
-
Gainesville, Florida, Forente stater, 32608
- Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054
-
Maitland, Florida, Forente stater, 32751
- Neurology Associates - Maitland- Site Number : 8400010
-
Orlando, Florida, Forente stater, 32806
- Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060
-
Tampa, Florida, Forente stater, 33609
- Axiom Clinical Research of Florida- Site Number : 8400049
-
Tampa, Florida, Forente stater, 33612
- University of South Florida- Site Number : 8400013
-
West Palm Beach, Florida, Forente stater, 33407
- Palm Beach Neurology- Site Number : 8400105
-
-
Georgia
-
Smyrna, Georgia, Forente stater, 30080
- Joi Life Wellness Group LLC- Site Number : 8400192
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60612
- Rush University Medical Center- Site Number : 8400102
-
Chicago, Illinois, Forente stater, 60637
- University of Chicago Medical Center- Site Number : 8400055
-
Northbrook, Illinois, Forente stater, 60062
- Consultants in Neurology- Site Number : 8400020
-
-
Indiana
-
Merrillville, Indiana, Forente stater, 46410
- Neuroscience Institute Center- Site Number : 8400053
-
-
Iowa
-
Iowa City, Iowa, Forente stater, 52242-1009
- University of Iowa- Site Number : 8400029
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66103
- University of Kansas Medical Center- Site Number : 8400084
-
-
Kentucky
-
Lexington, Kentucky, Forente stater, 40503
- Baptist Health Lexington- Site Number : 8400149
-
-
Louisiana
-
Alexandria, Louisiana, Forente stater, 71301
- NeuroMedical Clinic of Central Louisiana- Site Number : 8400159
-
New Orleans, Louisiana, Forente stater, 70121
- Ochsner Medical Center - Jefferson Highway- Site Number : 8400027
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- University of Maryland School of Medicine - Baltimore- Site Number : 8400185
-
Baltimore, Maryland, Forente stater, 21287
- Johns Hopkins Hospital- Site Number : 8400080
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02111
- Tufts Medical Center- Site Number : 8400003
-
Boston, Massachusetts, Forente stater, 02131
- Boston Clinical Trials- Site Number : 8400178
-
Foxborough, Massachusetts, Forente stater, 02035
- Neurology Center of New England- Site Number : 8400164
-
Wellesley, Massachusetts, Forente stater, 02481
- The Elliot Lewis Center- Site Number : 8400033
-
Worcester, Massachusetts, Forente stater, 01655
- UMass Memorial Medical Center - University Campus- Site Number : 8400028
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Henry Ford Hospital- Site Number : 8400091
-
Farmington Hills, Michigan, Forente stater, 48334
- Michigan Institute for Neurological Disorders- Site Number : 8400004
-
Grand Rapids, Michigan, Forente stater, 49503
- Trinity Health Grand Rapids- Site Number : 8400150
-
Owosso, Michigan, Forente stater, 48867
- Memorial Healthcare Institute for Neuroscience- Site Number : 8400123
-
Rochester Hills, Michigan, Forente stater, 48307
- Rochester Medical Group- Site Number : 8400172
-
-
Minnesota
-
Golden Valley, Minnesota, Forente stater, 55422
- Minneapolis Clinic of Neurology - Golden Valley- Site Number : 8400077
-
Minneapolis, Minnesota, Forente stater, 55455
- M Health Fairview University of Minnesota Medical Center - East Bank- Site Number : 8400056
-
Plymouth, Minnesota, Forente stater, 55446
- Minnesota Center for Multiple Sclerosis- Site Number : 8400073
-
-
Missouri
-
Ozark, Missouri, Forente stater, 65721
- Sharlin Health and Neurology- Site Number : 8400016
-
St Louis, Missouri, Forente stater, 63110
- Washington University- Site Number : 8400076
-
-
Nevada
-
Las Vegas, Nevada, Forente stater, 89106
- Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas- Site Number : 8400045
-
Reno, Nevada, Forente stater, 89502
- Renown Regional Medical Center- Site Number : 8400066
-
-
New Jersey
-
Teaneck, New Jersey, Forente stater, 07666
- Holy Name Medical Center- Site Number : 8400101
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87106
- The University of New Mexico- Site Number : 8400090
-
-
New York
-
Amherst, New York, Forente stater, 14226
- Dent Neurologic Institute - Amherst- Site Number : 8400129
-
New York, New York, Forente stater, 10029
- Icahn School of Medicine at Mount Sinai- Site Number : 8400011
-
New York, New York, Forente stater, 10032
- Columbia University Irving Medical Center- Site Number : 8400088
-
-
North Carolina
-
Charlotte, North Carolina, Forente stater, 28210
- Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
-
Raleigh, North Carolina, Forente stater, 27607
- Raleigh Neurology Associates- Site Number : 8400014
-
Winston-Salem, North Carolina, Forente stater, 27103
- Atrium Health - Wake Forest Baptist - Shepherd- Site Number : 8400040
-
-
North Dakota
-
Fargo, North Dakota, Forente stater, 58103
- Sanford Brain and Spine Center- Site Number : 8400085
-
-
Ohio
-
Cincinnati, Ohio, Forente stater, 45212
- Riverhills Neuroscience- Site Number : 8400007
-
Cincinnati, Ohio, Forente stater, 45219
- University of Cincinnati Medical Center- Site Number : 8400117
-
Columbus, Ohio, Forente stater, 43210
- The Ohio State University- Site Number : 8400009
-
Columbus, Ohio, Forente stater, 43235
- The Boster Center for Multiple Sclerosis- Site Number : 8400006
-
Dayton, Ohio, Forente stater, 45408
- UC Health - Elizabeth Place- Site Number : 8400008
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- Oklahoma Medical Research Foundation- Site Number : 8400039
-
-
Oregon
-
Portland, Oregon, Forente stater, 97225
- Providence St. Vincent's Medical Center- Site Number : 8400052
-
-
Pennsylvania
-
Hershey, Pennsylvania, Forente stater, 17033
- Penn State Health Milton South Hershey Medical Center- Site Number : 8400176
-
-
South Carolina
-
Greer, South Carolina, Forente stater, 29650
- Premier Neurology- Site Number : 8400047
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37215
- Vanderbilt Multiple Sclerosis Center- Site Number : 8400130
-
-
Texas
-
Dallas, Texas, Forente stater, 75243
- Neurology Consultants of Dallas - Lyndon B Johnson Freeway- Site Number : 8400152
-
Plano, Texas, Forente stater, 75024
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083
-
San Antonio, Texas, Forente stater, 78258
- Neurology Center of San Antonio- Site Number : 8400099
-
Sherman, Texas, Forente stater, 75092
- Texas Institute for Neurological Disorders - Sherman- Site Number : 8400018
-
-
Vermont
-
Burlington, Vermont, Forente stater, 05401
- University of Vermont Medical Center- Site Number : 8400042
-
-
Virginia
-
Fairfax, Virginia, Forente stater, 22031
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive- Site Number : 8400109
-
-
Washington
-
Seattle, Washington, Forente stater, 98104
- Swedish Medical Center - Seattle- Site Number : 8400078
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forente stater, 53226
- Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038
-
-
-
-
-
Créteil, Frankrike, 94010
- Investigational Site Number : 2500005
-
Gonesse, Frankrike, 95500
- Investigational Site Number : 2500017
-
La Tronche, Frankrike, 38700
- Investigational Site Number : 2500006
-
Lille, Frankrike, 59037
- Investigational Site Number : 2500009
-
Nancy, Frankrike, 54035
- Investigational Site Number : 2500016
-
Nice, Frankrike, 06001
- Investigational Site Number : 2500002
-
Orsay, Frankrike, 91400
- Investigational Site Number : 2500018
-
Paris, Frankrike, 75019
- Investigational Site Number : 2500007
-
Paris, Frankrike, 75651
- Investigational Site Number : 2500014
-
Rennes, Frankrike, 35033
- Investigational Site Number : 2500003
-
Saint-Herblain, Frankrike, 44800
- Investigational Site Number : 2500010
-
Strasbourg, Frankrike, 67200
- Investigational Site Number : 2500001
-
-
-
-
-
Athens, Hellas, 124 62
- Investigational Site Number : 3000005
-
Athens, Hellas, 115 25
- Investigational Site Number : 3000003
-
Ioannina, Hellas, 455 00
- Investigational Site Number : 3000004
-
Larissa, Hellas, 411 10
- Investigational Site Number : 3000001
-
Thessaloniki, Hellas, 546 36
- Investigational Site Number : 3000002
-
-
-
-
-
Bengaluru, India, 560022
- Investigational Site Number : 3560024
-
Hyderabad, India, 500082
- Investigational Site Number : 3560008
-
New Delhi, India, 110029
- Investigational Site Number : 3560017
-
Shimla, India, 171001
- Investigational Site Number : 3560006
-
-
-
-
-
Bologna, Italia, 40139
- Investigational Site Number : 3800009
-
Chieti, Italia, 66100
- Investigational Site Number : 3800014
-
Foggia, Italia, 71100
- Investigational Site Number : 3800019
-
Novara, Italia, 28100
- Investigational Site Number : 3800026
-
Palermo, Italia, 90127
- Investigational Site Number : 3800017
-
Parma, Italia, 43100
- Investigational Site Number : 3800029
-
Pavia, Italia, 27100
- Investigational Site Number : 3800005
-
Perugia, Italia, 06156
- Investigational Site Number : 3800003
-
Ravenna, Italia, 48121
- Investigational Site Number : 3800030
-
-
Catania
-
Augusta, Catania, Italia, 96011
- Investigational Site Number : 3800034
-
-
Ferrara
-
Cona, Ferrara, Italia, 44124
- Investigational Site Number : 3800025
-
-
Firenze
-
Florence, Firenze, Italia, 50134
- Investigational Site Number : 3800004
-
-
Genova
-
Genoa, Genova, Italia, 16132
- Investigational Site Number : 3800011
-
-
Milano
-
Milan, Milano, Italia, 20132
- Investigational Site Number : 3800002
-
Milan, Milano, Italia, 20133
- Investigational Site Number : 3800016
-
-
Napoli
-
Naples, Napoli, Italia, 80131
- Investigational Site Number : 3800010
-
-
Palermo
-
Cefalù, Palermo, Italia, 90015
- Investigational Site Number : 3800006
-
-
Roma
-
Rome, Roma, Italia, 00149
- Investigational Site Number : 3800001
-
Rome, Roma, Italia, 00161
- Investigational Site Number : 3800013
-
Rome, Roma, Italia, 00168
- Investigational Site Number : 3800021
-
-
Varese
-
Gallarate, Varese, Italia, 21013
- Investigational Site Number : 3800035
-
-
-
-
-
Chiba, Japan, 260-8677
- Investigational Site Number : 3920002
-
Fukuoka, Japan, 812-8582
- Investigational Site Number : 3920013
-
Joyo-Shi, Japan, 610-0113
- Investigational Site Number : 3800008
-
Kyoto, Japan, 616-8255
- Investigational Site Number : 3920001
-
Tokyo, Japan, 145-0065
- Investigational Site Number : 3920011
-
Tokyo, Japan, 160-8582
- Investigational Site Number : 3920012
-
Toyama, Japan, 939-2716
- Investigational Site Number : 2500015
-
-
Fukushima
-
Kōriyama, Fukushima, Japan, 963-8052
- Investigational Site Number : 3920003
-
-
Hokkaido
-
Asahikawa, Hokkaido, Japan, 070-0901
- Investigational Site Number : 3920014
-
-
Hyōgo
-
Himeji, Hyōgo, Japan, 670-8560
- Investigational Site Number : 3920007
-
-
Kanagawa
-
Sagamihara, Kanagawa, Japan, 252-0315
- Investigational Site Number : 3920010
-
-
Saitama
-
Higashi-Matsuyama, Saitama, Japan, 355-0005
- Investigational Site Number : 3920015
-
-
Tokyo
-
Kodaira, Tokyo, Japan, 187-8551
- Investigational Site Number : 3920016
-
-
-
-
-
Beijing, Kina, 100034
- Investigational Site Number : 1560005
-
Beijing, Kina, 100005
- Investigational Site Number : 1560007
-
Beijing, Kina, 100050
- Investigational Site Number : 1560008
-
Changchun, Kina, 130021
- Investigational Site Number : 1560003
-
Changsha, Kina, 410008
- Investigational Site Number : 1560011
-
Chengdu, Kina, 610041
- Investigational Site Number : 1560004
-
Fuzhou, Kina, 350005
- Investigational Site Number : 1560045
-
Guangzhou, Kina, 510630
- Investigational Site Number : 1560002
-
Harbin, Kina, 150001
- Investigational Site Number : 1561027
-
Jiazhuang, Kina, 050000
- Investigational Site Number : 1560010
-
Shanghai, Kina, 200040
- Investigational Site Number : 1560001
-
Taiyuan, Kina, 030001
- Investigational Site Number : 1560006
-
Tianjin, Kina, 300121
- Investigational Site Number : 1560012
-
Wuhan, Kina, 430030
- Investigational Site Number : 1560009
-
Xi'an, Kina, 710038
- Investigational Site Number : 1560013
-
Zhengzhou, Kina, 450052
- Investigational Site Number : 1560034
-
-
-
-
-
Rotterdam, Nederland, 3015 CE
- Investigational Site Number : 5280002
-
-
-
-
-
Katowice, Polen, 40571
- Investigational Site Number : 6160011
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polen, 60-309
- Investigational Site Number : 6160012
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Polen, 85-796
- Investigational Site Number : 6160018
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polen, 31-501
- Investigational Site Number : 6160005
-
-
Podkarpackie Voivodeship
-
Rzeszów, Podkarpackie Voivodeship, Polen, 35-055
- Investigational Site Number : 6160006
-
-
Podlaskie Voivodeship
-
Bialystok, Podlaskie Voivodeship, Polen, 15-276
- Investigational Site Number : 6160007
-
-
Silesian Voivodeship
-
Katowice, Silesian Voivodeship, Polen, 40-081
- Investigational Site Number : 6160010
-
Zabrze, Silesian Voivodeship, Polen, 41-800
- Investigational Site Number : 6160004
-
-
-
-
-
Braga, Portugal, 4710-243
- Investigational Site Number : 6200001
-
Lisbon, Portugal, 1649-035
- Investigational Site Number : 6200006
-
Lisbon, Portugal, 1349-019
- Investigational Site Number : 6200007
-
Lisbon, Portugal, 1169-050
- Investigational Site Number : 6200011
-
Matosinhos Municipality, Portugal, 4464-513
- Investigational Site Number : 6200002
-
-
-
-
-
Riyadh, Saudi-Arabia, 11461
- Investigational Site Number : 6820001
-
-
-
-
-
Córdoba, Spania, 14004
- Investigational Site Number : 7240004
-
Madrid, Spania, 28034
- Investigational Site Number : 7240002
-
Madrid, Spania, 28006
- Investigational Site Number : 7240006
-
Madrid, Spania, 28007
- Investigational Site Number : 7240023
-
Madrid, Spania, 28040
- Investigational Site Number : 7240003
-
Madrid, Spania, 28040
- Investigational Site Number : 7240022
-
Málaga, Spania, 29010
- Investigational Site Number : 7240005
-
Valencia, Spania, 46026
- Investigational Site Number : 7240008
-
Zaragoza, Spania, 50009
- Investigational Site Number : 7240025
-
-
Almería
-
Murcia, Almería, Spania, 30120
- Investigational Site Number : 7240018
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], Spania, 08035
- Investigational Site Number : 7240010
-
Barcelona, Barcelona [Barcelona], Spania, 08003
- Investigational Site Number : 7240016
-
-
Basque Country
-
Barakaldo, Basque Country, Spania, 48903
- Investigational Site Number : 7240009
-
-
Catalunya [Cataluña]
-
L'Hospitalet de Llobregat, Catalunya [Cataluña], Spania, 08907
- Investigational Site Number : 7240011
-
-
Gipuzkoa
-
Donostia / San Sebastian, Gipuzkoa, Spania, 20014
- Investigational Site Number : 7240012
-
-
Girona [Gerona]
-
Girona, Girona [Gerona], Spania, 17190
- Investigational Site Number : 7240024
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, Spania, 35010
- Investigational Site Number : 7240013
-
-
Lleida [Lérida]
-
Lleida, Lleida [Lérida], Spania, 25198
- Investigational Site Number : 7240015
-
-
Madrid
-
Majadahonda, Madrid, Spania, 28222
- Investigational Site Number : 7240017
-
Pozuelo de Alarcón, Madrid, Spania, 28223
- Investigational Site Number : 7240001
-
-
Pontevedra [Pontevedra]
-
Pontevedra, Pontevedra [Pontevedra], Spania, 36312
- Investigational Site Number : 7240014
-
-
Sevilla
-
Seville, Sevilla, Spania, 41009
- Investigational Site Number : 7240007
-
-
-
-
-
Liverpool, Storbritannia, L97LJ
- Investigational Site Number : 8260009
-
-
Blaenau Gwent
-
Gwent, Blaenau Gwent, Storbritannia, NP20 2UB
- Investigational Site Number : 8260011
-
-
Cardiff [Caerdydd Gb-crd]
-
Cardiff, Cardiff [Caerdydd Gb-crd], Storbritannia, CF14 4XW
- Investigational Site Number : 8260007
-
-
Devon
-
Exeter, Devon, Storbritannia, EX2 5DW
- Investigational Site Number : 8260001
-
-
England
-
London, England, Storbritannia, E11 1NR
- Investigational Site Number : 8260013
-
Newcastle upon Tyne, England, Storbritannia, NE2 4HH
- Investigational Site Number : 8260006
-
-
Highland
-
Inverness, Highland, Storbritannia, IV2 3UJ
- Investigational Site Number : 8260010
-
-
Kent
-
Canterbury, Kent, Storbritannia, CT1 3NG
- Investigational Site Number : 8260003
-
-
Manchester
-
Salford, Manchester, Storbritannia, M6 8HD
- Investigational Site Number : 8260008
-
-
Oxfordshire
-
Oxford, Oxfordshire, Storbritannia, OX3 9DU
- Investigational Site Number : 8260004
-
-
Swansea [Abertawe Gb-ata]
-
Swansea, Swansea [Abertawe Gb-ata], Storbritannia, SA6 6SG
- Investigational Site Number : 8260005
-
-
-
-
-
Gothenburg, Sverige, 413 45
- Investigational Site Number : 7520001
-
Huddinge, Sverige, 141 57
- Investigational Site Number : 7520005
-
Malmö, Sverige, 205 02
- Investigational Site Number : 7520003
-
Stockholm, Sverige, 113 65
- Investigational Site Number : 7520002
-
-
-
-
Gyeonggi-do
-
Goyang-si, Gyeonggi-do, Sør -Korea, 10408
- Investigational Site Number : 4100001
-
Seongnam-si, Gyeonggi-do, Sør -Korea, 13620
- Investigational Site Number : 4100007
-
-
Seoul-teukbyeolsi
-
Seoul, Seoul-teukbyeolsi, Sør -Korea, 03080
- Investigational Site Number : 4100002
-
Seoul, Seoul-teukbyeolsi, Sør -Korea, 03722
- Investigational Site Number : 4100004
-
Seoul, Seoul-teukbyeolsi, Sør -Korea, 06351
- Investigational Site Number : 4100003
-
-
-
-
-
Brno, Tsjekkia, 625 00
- Investigational Site Number : 2030011
-
Brno, Tsjekkia, 656 91
- Investigational Site Number : 2030005
-
Hradec Králové, Tsjekkia, 500 05
- Investigational Site Number : 2030002
-
Jihlava, Tsjekkia, 586 01
- Investigational Site Number : 2030006
-
Ostrava, Tsjekkia, 708 52
- Investigational Site Number : 2030007
-
Prague, Tsjekkia, 150 06
- Investigational Site Number : 2030008
-
Teplice, Tsjekkia, 415 01
- Investigational Site Number : 2030009
-
Zlín, Tsjekkia, 762 75
- Investigational Site Number : 2030001
-
-
-
-
-
Ankara, Tyrkia (Türkiye), 06010
- Investigational Site Number : 7920018
-
Ankara, Tyrkia (Türkiye), 06800
- Investigational Site Number : 7920011
-
Bursa, Tyrkia (Türkiye), 16059
- Investigational Site Number : 7920020
-
Bursa, Tyrkia (Türkiye), 16310
- Investigational Site Number : 7920013
-
Eskişehir, Tyrkia (Türkiye), 26480
- Investigational Site Number : 7920005
-
Istanbul, Tyrkia (Türkiye), 34098
- Investigational Site Number : 7920002
-
Istanbul, Tyrkia (Türkiye), 34785
- Investigational Site Number : 7920007
-
Istanbul, Tyrkia (Türkiye), 34668
- Investigational Site Number : 7920009
-
Istanbul, Tyrkia (Türkiye), 34010
- Investigational Site Number : 7920012
-
Istanbul, Tyrkia (Türkiye), 34200
- Investigational Site Number : 7920016
-
Izmir, Tyrkia (Türkiye), 35340
- Investigational Site Number : 7920019
-
Izmir, Tyrkia (Türkiye), 35360
- Investigational Site Number : 7920008
-
Kayseri, Tyrkia (Türkiye), 38039
- Investigational Site Number : 7920014
-
Konya, Tyrkia (Türkiye), 42075
- Investigational Site Number : 7920015
-
Mersin, Tyrkia (Türkiye), 33070
- Investigational Site Number : 7920006
-
Samsun, Tyrkia (Türkiye), 55139
- Investigational Site Number : 7920004
-
Sultangazi, Tyrkia (Türkiye), 34265
- Investigational Site Number : 7920003
-
Van, Tyrkia (Türkiye), 65080
- Investigational Site Number : 7920017
-
İzmit, Tyrkia (Türkiye), 41001
- Investigational Site Number : 7920001
-
-
-
-
-
Bielefeld, Tyskland, 33647
- Investigational Site Number : 2760009
-
Bochum, Tyskland, 44791
- Investigational Site Number : 2760010
-
Dresden, Tyskland, 01307
- Investigational Site Number : 2760012
-
Düsseldorf, Tyskland, 40225
- Investigational Site Number : 2760002
-
Erbach im Odenwald, Tyskland, 64711
- Investigational Site Number : 2760013
-
Essen, Tyskland, 45147
- Investigational Site Number : 2760011
-
Heidelberg, Tyskland, 69117
- Investigational Site Number : 2760014
-
Jena, Tyskland, 07747
- Investigational Site Number : 2760007
-
Leipzig, Tyskland, 04103
- Investigational Site Number : 2760003
-
Marburg, Tyskland, 35043
- Investigational Site Number : 2760008
-
Münster, Tyskland, 48149
- Investigational Site Number : 2760006
-
Ulm, Tyskland, 89073
- Investigational Site Number : 2760001
-
-
-
-
-
Chernivtsi, Ukraina, 58023
- Investigational Site Number : 8040001
-
Ivano-Frankivsk, Ukraina, 76019
- Investigational Site Number : 8040009
-
Krykhivtsi, Ukraina, 76493
- Investigational Site Number : 8040003
-
Kyiv, Ukraina, 02091
- Investigational Site Number : 8040006
-
Lutsk, Ukraina, 43005
- Investigational Site Number : 8040008
-
Lviv, Ukraina, 79010
- Investigational Site Number : 8040004
-
Lviv, Ukraina, 79029
- Investigational Site Number : 8040002
-
Vinnytsia, Ukraina, 21050
- Investigational Site Number : 8040005
-
-
-
-
-
Budapest, Ungarn, 1033
- Investigational Site Number : 3480003
-
Budapest, Ungarn, 1138
- Investigational Site Number : 3480004
-
Budapest, Ungarn, 1145
- Investigational Site Number : 3480006
-
Győr, Ungarn, 9024
- Investigational Site Number : 3480002
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Participant must have a previous diagnosis of RRMS in accordance with the 2017 revised McDonald criteria.
- Participant must have a current diagnosis of SPMS in accordance with the clinical course criteria revised in 2013 endorsed by an Adjudication Committee.
- Participant must have documented evidence of disability progression observed during the 12 months before screening. Eligibility will be analyzed by an Adjudication Committee.
- Absence of clinical relapses for at least 24 months.
- The participant must have an EDSS score at screening from 3.0 to 6.5 points, inclusive.
- Contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
- For patients eligible to be treated with siponimod: 1) does not tolerate it due to side effects or safety reasons, or 2) has failed siponimod treatment due to perceived lack of efficacy, or 3) has declined siponimod treatment.
Exclusion Criteria:
- The participant has a history of infection or may be at risk for infection.
- The presence of psychiatric disturbance or substance abuse.
- History, clinical evidence, suspicion or significant risk for thromboembolic events, as well as myocardial infarction, stroke, and/or antiphosholipid syndrome and any participants requiring antithrombotic treatment.
- Current hypogammaglobulinemia defined by immunoglobulin levels (IgG and/or IgM) below the lower limits of normal (LLN) at Screening or a history of primary hypogammaglobulinemia. Patients with a history of secondary hypogammaglobulinemia induced by anti-C20 monoclonal antibodies (eg, ocrelizumab, ofatumumab, ublituximab, rituximab) may be considered for study inclusion provided their immunoglobulin levels are within the normal limits (WNL) at time of Screening.
- A history or presence of disease that can mimic MS symptoms, such as, but not limited to neuromyelitis optica spectrum disorder, systemic lupus erythematosus, Sjogren's syndrome, acute disseminated encephalomyelitis, and myasthenia gravis.
- The participant has sensitivity to any of the study interventions, or components thereof, or has a drug or other allergy that, in the opinion of the Investigator, contraindicates participation in the study.
- The participant was previously exposed to frexalimab.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Placebo komparator: Placebo
Matching placebo |
IV, as per respective label Solution for IV infusion |
|
Eksperimentell: Frexalimab
Frexalimab IV administration |
SAR441344 Solution for IV infusion IV, as per respective label |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to onset of composite confirmed disability progression (cCDP) confirmed over 6 months in the double-blind treatment period
Tidsramme: Up to 36 months
|
Defined as Increase from the baseline expanded disability status scale (EDSS) score of ≥1.0 point when the baseline is <5.5, or ≥0.5 point when the baseline is ≥5.5, OR Increase of ≥20% from the baseline time in the 9 hole peg test (9HPT),OR Increase of ≥20% from the baseline time in the timed 25 foot walk (T25FW) test |
Up to 36 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Tid til begynnelse av sammensatt CCDP bekreftet over 3 måneder i den dobbeltblinde behandlingsperioden
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Prosentvis endring i tap av hjernevolum som detektert av MR-skanninger på slutten av dobbeltblind behandlingsperiode sammenlignet med måned 6
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Endring i kognitiv funksjon ved slutten av dobbeltblind behandlingsperiode sammenlignet med baseline som vurdert ved symbolsifrede modaliteter test (SDMT)
Tidsramme: Baseline, opptil 36 måneder
|
Baseline, opptil 36 måneder
|
|
|
Endring fra baseline i multippel sklerose Impact Scale 29 versjon 2 (MSIS-29V2) Spørreskjema score over tid i den dobbeltblinde behandlingsperioden
Tidsramme: Baseline, opptil 36 måneder
|
Baseline, opptil 36 måneder
|
|
|
Endring fra baseline hos pasient rapportert utfallsmålingsinformasjonssystem (PROMIS) utmattelse Multiple Sclerosis (MS) -8a over tid i den dobbeltblinde behandlingsperioden
Tidsramme: Baseline, opptil 36 måneder
|
Baseline, opptil 36 måneder
|
|
|
Årlig tilbakefall av tilbakefall i den dobbeltblinde behandlingsperioden vurdert med protokolldefinerte dømte tilbakefall
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Antall deltakere med bivirkninger, SAE -er, AE -er som fører til permanent deling av studier og AE av spesielle interesser (AESIS)
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Antall deltakere med antistoff over tid
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Endre fra baseline i serum Ig -nivåer over tid
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Endring fra baseline i plasma neurofilament lett kjede (NFL) nivåer over tid i den dobbeltblinde behandlingsperioden
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Frexalimab plasmakonsentrasjon over tid i den dobbeltblinde behandlingsperioden
Tidsramme: Opptil 36 måneder
|
Opptil 36 måneder
|
|
|
Time to onset of individual components of the composite, confirmed over 3-months or 6 months in the double-blind treatment period
Tidsramme: Up to 36 months
|
increase from the baseline EDSS score of ≥1.0 point when the baseline is <5.5, or ≥0.5 point when the baseline is ≥5.5 |
Up to 36 months
|
|
Time to onset of confirmed disability improvement (CDI) in the double-blind treatment period
Tidsramme: Up to 36 months
|
defined as decrease from the baseline EDSS score of ≥1.0 or ≥ 0.5 points when baseline is ≤5.5 or >5.5 points, respectively, confirmed over 6 months. |
Up to 36 months
|
|
Number of new and/or enlarging T2 hyperintense lesions per year as detected by MRI
Tidsramme: Up to 36 months
|
defined as the sum of the individual number of new and/or enlarging T2-hyperintense lesions at all scheduled visits starting after baseline up to the end of double-blind treatment period |
Up to 36 months
|
|
Number of participants with potentially clinically significant abnormalities (PCSAs) in laboratory tests, ECG, and vital signs during the study period
Tidsramme: Up to 36 months
|
12-lead ECG (electrocardiogram) will be obtained using an ECG machine that automatically calculates the heart rate and measures PR, QRS, QT, and QTc intervals. |
Up to 36 months
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- EFC17504
- U1111-1280-7114 (Registeridentifikator: ICTRP)
- 2023-504359-29 (Registeridentifikator: CTIS)
- 2023 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .